Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity and its associated disorders, such as insulin resistance, dyslipidemia, metabolic inflammation, dysbiosis, and non-alcoholic hepatic steatosis, are involved in several molecular and inflammatory mechanisms that alter the metabolism. Food habit changes, such as the quality of fatty acids in the diet, are proposed to treat and prevent these disorders. Some studies demonstrated that saturated fatty acids (SFA) are considered detrimental for treating these disorders. A high fat diet rich in palmitic acid, a SFA, is associated with lower insulin sensitivity and it may also increase atherosclerosis parameters. On the other hand, a high intake of eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids may promote positive effects, especially on triglyceride levels and increased high-density lipoprotein (HDL) levels. Moreover, polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) are effective at limiting the hepatic steatosis process through a series of biochemical events, such as reducing the markers of non-alcoholic hepatic steatosis, increasing the gene expression of lipid metabolism, decreasing lipogenic activity, and releasing adiponectin. This current review shows that the consumption of unsaturated fatty acids, MUFA, and PUFA, and especially EPA and DHA, which can be applied as food supplements, may promote effects on glucose and lipid metabolism, as well as on metabolic inflammation, gut microbiota, and hepatic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“For many years, highlighting the consumption pattern of lipid content and quality in the diet, aiming at a reduction in the consumption of saturated fatty acids, was a key component of an obesity-targeted diet [16,17].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“[110], in which they evaluated children who consumed two types of diets: one traditionally rural and one urban.”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“The main factors responsible for the development of type 2 diabetes mellitus (DM II) are the high production of hepatic glucose, impaired insulin secretion, and insulin resistance, which is common in obesity [19].”
BackgroundFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 2×
“Different compositions and even administration of strains, such as bifidiobacteria, may influence the production of proinflammatory cytokines [108].”
BackgroundCinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245 · cited 1×
“These kind of PUFAs are classified as omega-3 (ω-3) and omega-6 (ω-6) [13].”
BackgroundVessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 1×
“A diet rich in unsaturated fatty acids, present in oilseeds, plays an important role in the prevention of insulin resistance, increasing insulin affinity for the receptors [47].”
BackgroundCholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953 · cited 2×
“This mechanism may improve the atherosclerosis protection due to the fact that n-3-PUFAs act in reverse cholesterol trafficking [71].”
BackgroundLoss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Borkman, M., Storlien, L. H., Pan, D. A., Jenkins, A. B., Chisholm, D. J., & Campbell, L. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280404 · Cited by 835 · cited 1×
“The therapeutic potential of n-PUFA is important because it mediates the biological processes, such as eicosanoid production [86], which creates signaling molecules including leukotrienes, prostaglandins, thromboxane, and prostacyclins.”
BackgroundRyan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722 · cited 1×
“Toll-like receptors are a defense of the organism against invading pathogens by proinflammatory cytokines in immune cells, but when TLR signaling is overactivated, altering the TLR tolerance, these conditions may result in a large number of proinflammatory cytokines that lead to tissue damage [145].”
BackgroundCsak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
Lam, Y. Y., Ha, C. W. Y., Campbell, C. R., Mitchell, A. J., Dinudom, A., Oscarsson, J., Cook, D. I., Hunt, N. H., Caterson, I. D., Holmes, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034233 · Cited by 604 · cited 2×
“Female rats Control group (10% kcal fat), high Fat (60% kcal fat, of which 34% was SFA) ↑ Firmicutes and ↓ Bacteroidetes ↑ Inflammatory citokines [100]”
BackgroundMethodLopez-Garcia, E., Schulze, M. B., Meigs, J. B., Manson, J. E., Rifai, N., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.562 · Cited by 600 · cited 1×
“One of the reasons for changing these habits is to improve the quality of lipids consumed in the diet, involving recommendations to reduce SFAs, which are associated with the dyslidemia process because they cause an increase in LDL, which is due to a reduction in the production and activity of the LDLR gene, related t…”
BackgroundFiber and Magnesium Intake and Incidence of Type 2 Diabetes: A Prospective Study and Meta-analysis
Schulze, M. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.956 · Cited by 537
Rodríguez-Morán, M., & Guerrero-Romero, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1147 · Cited by 429 · cited 1×
“Furthermore, the composition of oilseeds with high magnesium [48,49], high fiber content [50,51], and low glycemic index [52,53] have also been linked to a lower risk of diabetes.”
BackgroundWhy do omega-3 fatty acids lower serum triglycerides?
Harris, W. S., & Bulchandani, D. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236363.63840.16 · Cited by 398
Polyunsaturated fatty acid synthesis: What will they think of next?
Wallis, J. G., Watts, J. L., & Browse, J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02168-0 · Cited by 375 · cited 1×
“These FAs are defined as essential fatty acids because they cannot be synthesized in human cells, and therefore must be obtained from dietary linoleic acid (C18:2 n-6) and α-linolenic acid (C18:3 n-3) [15].”
BackgroundFish oil — How does it reduce plasma triglycerides?
Shearer, G. C., Savinova, O. V., & Harris, W. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.011 · Cited by 285
Zelber‐Sagi, S., Salomone, F., & Mlynarsky, L. (2017) · Liver International · doi:10.1111/liv.13435 · Cited by 273 · cited 1×
“Among these non-pharmacological approaches are weight reduction, which involves strategies like bariatric surgery, some type of diets, and physical activity [119].”
BackgroundBozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., Mazzarella, R., Longobardo, M., Mancini, M., Vigorito, C., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0033 · Cited by 227 · cited 1×
“The MUFA intake also showed positive results on the glucose parameters, with a statistically significant reduction in the HbA1c levels [30].”
BackgroundMoya-Pérez, A., Neef, A., & Sanz, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126976 · Cited by 211 · cited 1×
“[89] (Table 6) showed that high fat (HF) diets are responsible for increasing the infiltration of lymphocytes B in rats, which are the first cells in the immune system to be recruited from adipose tissue after administration of these diets.”
BackgroundSawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., Yamashita, S., Oishi, S., Osue, T., Yokoi, K., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0437-y · Cited by 97
Parlevliet, E. T., Wang, Y., Geerling, J. J., Schröder-Van der Elst, J. P., Picha, K., O'Neil, K., Stojanovic-Susulic, V., Ort, T., Havekes, L. M., Romijn, J. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049152 · Cited by 97 · cited 1×
“The data showed that a diet rich in SFA exerted a hyperlipidemic effect only on the 30th day, but a long-term diet displayed beneficial effects on hyperlipidemia (Table 4) [73], which could be a consequence of the decrease in apolipoprotein synthesis and the formation of VLDL in the liver [74,75].”
BackgroundLytle, K. A., Depner, C. M., Wong, C. P., & Jump, D. B. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m061275 · Cited by 45 · cited 5×
“Some studies focused on evaluating the effects of WD to induce NASH in Ldlr−/− mice [134,143].”
BackgroundInfluential
Cited by
Grosso, G., Laudisio, D., Frias-Toral, E., Barrea, L., Muscogiuri, G., Savastano, S., & Colao, A. (2022) · Nutrients · doi:10.3390/nu14061137 · Cited by 255
Machate, D. J., Figueiredo, P. S., Marcelino, G., Guimarães, R. D. C. A., Hiane, P. A., Bogo, D., Pinheiro, V. A. Z., Oliveira, L. C. S. D., & Pott, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114093 · Cited by 243
Self-citationvan Zuuren, E. J., Fedorowicz, Z., Kuijpers, T., & Pijl, H. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy096 · Cited by 177
Bracko, O., Vinarcsik, L. K., Cruz Hernández, J. C., Ruiz-Uribe, N. E., Haft-Javaherian, M., Falkenhain, K., Ramanauskaite, E. M., Ali, M., Mohapatra, A., Swallow, M. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65908-y · Cited by 85
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61
Metadata
- Authors
- Silva Figueiredo, P., Carla Inada, A., Marcelino, G., Maiara Lopes Cardozo, C., De Cássia Freitas, K., De Cássia Avellaneda Guimarães, R., Pereira de Castro, A., Aragão do Nascimento, V., & Aiko Hiane, P.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-10-22
- Volume
- 9
- Issue
- 10
- Pages
- 1158
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2766366334
- Cited by
- 239
- References
- 27
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.